Stock listing
Endonovo Therapeutics, Inc.
Selected listing: ENDV · OTC · USD · US
Endonovo Therapeutics, Inc. (OTC:ENDV), Health Technology. Latest release Dec 4, 2023: Endonovo Signs Definitive Agreement to Sell SofPulse® Brand Business…
- Ticker
- OTC:ENDV
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Medical Specialties
- Exchange
- OTC
- Currency
- USD
About Endonovo Therapeutics, Inc.
Endonovo Therapeutics, Inc. is a public company traded under the ticker ENDV in the American market. Endonovo focuses on developing innovative therapeutic solutions, although specific product details and financial metrics are not provided.
Latest news from Endonovo Therapeutics, Inc.
Endonovo Signs Definitive Agreement to Sell SofPulse® Brand Business and IP to SofPulse Inc. for a minimum of $50 Million
December 3, 2023
Endonovo's SofPulse® Secures Taiwan FDA Approval
October 11, 2023
Endonovo’s SofPulse® Secures Federal Supply Schedule Inclusion to Accelerate Expansion of VA Distribution
August 21, 2023
Endonovo’s Breaking Barriers in With Patented Medical Technologies: 2023 Bi-Annual Update
August 7, 2023
New to The Street TV Signs 6 Part Series, Featuring Endonovo Therapeutics, Inc.
June 21, 2023
Research Endonovo Therapeutics, Inc.
Endonovo Therapeutics, Inc. company profile
View the public company page for Endonovo Therapeutics, Inc. on 6ix.
Endonovo Therapeutics, Inc. news
Read company news and market updates connected to Endonovo Therapeutics, Inc..
Endonovo Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Endonovo Therapeutics, Inc..